|

BAFF-R CART Clinical Trials

1 actively recruiting trial

Pipeline

Phase 1/2: 1

Top Sponsors

  • Tianjin Medical University General Hospital1

Indications

  • NMO Spectrum Disorder1
  • Idiopathic Inflammatory Myopathies1
  • Chronic Inflammatory Demyelinating Polyradiculoneuropathy1
  • Myasthenia Gravis1
  • Cancer1

Other1 trial

Safety and Efficacy of BAFF-R CART for Refractory Neuroimmune Diseases
Phase 1/2

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.